We are recruiting a Market Access & Pricing Lead based at our global headquarters in Meyrin, Switzerland. Reporting directly to the Head of Business Development & Alliance Management and as part of a team of three,
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
BeOne continues to grow at a rapid pace with challenging and exciting opportunities for experienced professionals. When considering candidates, we look for scientific and business professionals who are highly motivated, collaborative, and most importantly, share our
About This Role: The Global Launch and Commercial Operations Lead is a senior individual contributor accountable for the end‑to‑end governance, readiness, and execution excellence of Biogen’s global commercial launch of zorevunersen — a potential first-in-class disease-modifying
Job Summary We are seeking an experienced Events Manager to join our Marketing Operations & Communications team and lead the planning, execution, and continuous improvement of European events in the medical device industry. This role owns
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Are you ready to put a face to our mission in one of Switzerlands most dynamic healthcare regions? Join us in Geneva and the Jura as the trusted partner of general practitioners – translating science into
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
About Sanofi We’re an R&D-driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. Our deep understanding of the immune system – and innovative pipeline – enables us to invent medicines and vaccines
About Sanofi We’re an R&D-driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. Our deep understanding of the immune system – and innovative pipeline – enables us to invent medicines and vaccines
About Sanofi We’re an R&D-driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. Our deep understanding of the immune system – and innovative pipeline – enables us to invent medicines and vaccines
At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are,
Company Description About AbbVie At Allergan Aesthetics, an AbbVie company, we develop, manufacture, and market a portfolio of leading aesthetics brands and products. Our aesthetics portfolio includes facial injectables, body contouring, plastics, skin care, and more.
Position Summary The Senior Director, Head of Medical Evidence reports into the Vice President, Head of Disease Areas and coordinates with Medical Affairs and cross-functional stakeholders to lead the Integrated Evidence Generation Plans (IEGP) for all
We are recruiting a Market Access & Pricing Lead based at our global headquarters in Meyrin, Switzerland. Reporting directly to the Head of Business Development & Alliance Management and as part of a team of three,
About Sanofi We’re an R&D‑driven, AI‑powered biopharma company committed to improving people’s lives and delivering compelling growth. Our deep understanding of the immune system – and innovative pipeline – enables us to invent medicines and vaccines
Job Purpose The VP, Medical Affairs, Rare Diseases BU will provide strategic medical leadership and oversight to support the continued growth of the Rare Diseases (RRD) portfolio. S/he will champion patient centricity as key driver of